Agents for Change: Artificial Intelligent Workflows for Quantitative Clinical Pharmacology and Translational Sciences
Top Cited Papers
Open Access
- 8 March 2025
- journal article
- review article
- Published by Wiley in Clinical and Translational Science
- Vol. 18 (3) , e70188
Abstract
Artificial intelligence (AI) is making a significant impact across various industries, including healthcare, where it is driving innovation and increasing efficiency. In the fields of Quantitative Clinical Pharmacology (QCP) and Translational Sciences (TS), AI offers the potential to transform traditional practices through the use of agentic workflows—systems with different levels of autonomy where specialized AI agents work together to perform complex tasks, while keeping “human in the loop.” These workflows can simplify processes, such as data collection, analysis, modeling, and simulation, leading to greater efficiency and consistency. This review explores how these AI‐powered agentic workflows can help in addressing some of the current challenges in QCP and TS by streamlining pharmacokinetic and pharmacodynamic analyses, optimizing clinical trial designs, and advancing precision medicine. By integrating domain‐specific tools while maintaining data privacy and regulatory standards, well‐designed agentic workflows empower scientists to automate routine tasks and make more informed decisions. Herein, we showcase practical examples of AI agents in existing platforms that support QCP and biomedical research and offer recommendations for overcoming potential challenges involved in implementing these innovative workflows. Looking ahead, fostering collaborative efforts, embracing open‐source initiatives, and establishing robust regulatory frameworks will be key to unlocking the full potential of agentic workflows in advancing QCP and TS. These efforts hold the promise of speeding up research outcomes and improving the efficiency of drug development and patient care.Keywords
This publication has 18 references indexed in Scilit:
- Artificial Intelligence for Quantitative Modeling in Drug Discovery and Development: An Innovation and Quality Consortium Perspective on Use Cases and Best PracticesClinical Pharmacology & Therapeutics, 2023
- Revolutionizing healthcare: the role of artificial intelligence in clinical practiceBMC Medical Education, 2023
- A Survey on Explainable Artificial Intelligence (XAI): Toward Medical XAIIEEE Transactions on Neural Networks and Learning Systems, 2020
- History of artificial intelligence in medicineGastrointestinal Endoscopy, 2020
- Deep learning for healthcare: review, opportunities and challengesBriefings in Bioinformatics, 2017
- Application of a Neural Network for Gentamicin Concentration Prediction in a General Hospital PopulationTherapeutic Drug Monitoring, 1997
- Artificial Neural Networks As a Novel Approach to Integrated Pharmacokinetic—Pharmacodynamic AnalysisJournal of Pharmaceutical Sciences, 1996
- Feasibility of Developing a Neural Network for Prediction of Human Pharmacokinetic Parameters from Animal DataPharmaceutical Research, 1993
- Neural networks in pharmacodynamic modeling. Is current modeling practice of complex kinetic systems at a dead end?Journal of Pharmacokinetics and Biopharmaceutics, 1992
- Artificial Intelligence in Medical DiagnosisAnnals of Internal Medicine, 1988